Dexcom director gifts 10,074 DXCM shares
Dexcom director Steven R. Altman reported a bona fide gift of 10,074 shares of Dexcom common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Dexcom director Steven R. Altman reported a bona fide gift of 10,074 shares of Dexcom common stock. The filing shows two gift transactions of 5,037 shares each on common stock. Following these transactions, 63,667 shares are held indirectly through the Altman Family Trust, where Altman serves as trustee, and his direct holdings in these reported shares are now zero.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 5,037 | $0.00 | $0.00 |
| Gift | Common Stock | 5,037 | $0.00 | $0.00 |
Footnotes (2)
- F1. Shares were transferred from direct ownership to ownership under the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, upon vesting of previously awarded restricted stock units.
- F2. Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.
Key Figures
Key Terms
bona fide gift financial
restricted stock units financial
indirect ownership financial
Altman Family Trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Dexcom (DXCM) director Steven R. Altman report?
What role does the Altman Family Trust play in Steven R. Altman’s Dexcom (DXCM) holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.